A proposal to rename and classify aplastic anemia as Myeloaplastic syndrome (MAS) Type I and II

被引：0
|
作者：
Venniyoor, A. [1 ]
机构：
[1] Command Hosp CC, Dept Med & Oncol, Lucknow 226002, Uttar Pradesh, India
来源：
MEDICAL HYPOTHESES | 2010年 / 74卷 / 06期
关键词：
MYELOPROLIFERATIVE NEOPLASMS; CLASSIFICATION;
D O I：
10.1016/j.mehy.2010.01.034
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
引用
收藏
页码：1085 / 1086
页数：2
相关论文
共 50 条
  • [21] OTOPALATODIGITAL SYNDROME WITH FEATURES OF TYPE-I AND TYPE-II IN BROTHERS
    HORN, D
    NITZ, I
    BOLLMANN, R
    GENETIC COUNSELING, 1995, 6 (03): : 233 - 240
  • [22] CONGENITAL DYSERYTHROPOIETIC ANEMIA WITH ULTRASTRUCTURE FINDINGS COMPATIBLE WITH BOTH TYPE-I AND TYPE-II
    DVILANSKY, A
    SUKENIK, S
    STERN, J
    DJALDETTI, M
    ACTA HAEMATOLOGICA, 1974, 52 (03) : 161 - 168
  • [23] Phase II study of thymoglobulin, cyclosporine and G-CSF for initial treatment of aplastic anemia and low risk myelodysplastic syndrome
    Garg, R. J.
    Shah, N.
    Garcia-Manero, G.
    Faderl, S. Stefan
    Cortes, J. E.
    Koller, C.
    Beran, M.
    Borthakur, G.
    Kantarjian, H. M.
    Ravandi, F.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [24] Phase II study of thymoglobulin, cyclosporine,and G-CSF for the initial treatment of aplastic anemia and low risk myelodysplastic syndrome
    Ravandi, F.
    Faderl, S.
    Ferrajoli, A.
    Borthakur, G.
    Beran, M.
    Pierce, S.
    Koller, C.
    Cortes, J.
    Kantarjian, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 : 26 - 26
  • [25] Gilbert's syndrome accounts for the phenotypic variability of congenital dyserythropoietic anemia type II (CDA-II)
    Perrotta, S
    del Giudice, EM
    Carbone, R
    Servedio, V
    Schettini, F
    Nobili, B
    Iolascon, A
    JOURNAL OF PEDIATRICS, 2000, 136 (04): : 556 - 559
  • [26] Phase II study of thymglobulin, cyclosporin, and G-CSF for the initial treatment of aplastic anemia and low risk myelodysplastic syndrome.
    Ravandi-Kashani, Farhad
    Estrov, Zeev
    Ferrajoli, Alessandra
    Borthakur, Gaurarn
    Beran, Miloslav
    Pierce, Sherry
    Koller, Charles A.
    Cortes, Jorge
    Faderl, Stefan
    Kantarjian, Hagop M.
    BLOOD, 2006, 108 (11) : 292B - 292B
  • [27] Congenital dyserythropoietic anemia (CDA) with mixed type I and type II ultrastructural features: A case report.
    Boschetti, C
    Barraco, F
    Caneva, L
    Bianchi, P
    Mariani, M
    Vercellati, C
    Soligo, D
    Zanella, A
    BLOOD, 2001, 98 (11) : 11B - 11B
  • [28] Complex regional pain syndrome (type I, RSD; type II, causalgia): Controversies
    Stanton-Hicks, M
    CLINICAL JOURNAL OF PAIN, 2000, 16 (02): : S33 - S40
  • [29] RNA Sequencing of the Fetal Inflammatory Response Syndrome Type I and Type II.
    Para, Robert
    Romero, Roberto
    Miller, Derek
    Galaz, Jose
    Done, Bogdan
    Peyvandipour, Azam
    Gershater, Meyer
    Tao, Li
    Ruden, Douglas
    Isherwood, Jenna
    Pique-Regi, Roger
    Tarca, Adi L.
    Gomez-Lopez, Nardhy
    REPRODUCTIVE SCIENCES, 2021, 28 (SUPPL 1) : 301A - 301A
  • [30] A PHASE-I/II TRIAL OF RECOMBINANT GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR FOR CHILDREN WITH APLASTIC-ANEMIA
    GUINAN, EC
    SIEFF, CA
    OETTE, DH
    NATHAN, DG
    BLOOD, 1990, 76 (06) : 1077 - 1082
12345